Effects of seasonality and treatment on COPD clinical outcomes: IMPACT<i>post hoc</i>analysis
<b>IMPACT <i>post hoc</i> analysis identified higher COPD exacerbation rates in winter <i>versus</i> summer. Exacerbation risk was significantly reduced with FF/UMEC/VI <i>versus</i> dual therapy regardless of season, highlighting the durability of response with triple therapy.</b> https://bit.ly/47KAhmK.
Authors
- Gerard J. Criner (ORCID: https://orcid.org/0000-0003-1267-3483)
- MeiLan K. Han (ORCID: https://orcid.org/0000-0002-9095-4419)
- Lee Tombs
- David A. Lipson (ORCID: https://orcid.org/0000-0001-6732-4593)
Institutions
- University of Michigan (US)
- GlaxoSmithKline (United States) (US)
- University of Pennsylvania (US)
- Temple University (US)
Publication Details
- Journal
- ERJ Open Research
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1183/23120541.00583-2024
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- GlaxoSmithKline